Published in Kidney Int Suppl on February 01, 2001
An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int (2004) 1.76
Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. Oxid Med Cell Longev (2013) 1.34
Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol (2008) 1.17
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms. Clin Exp Nephrol (2008) 0.75
Haemorrhagic fever with renal syndrome, 1993: endemic or unrecognised pandemic? Lancet (1993) 3.77
Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen (1997) 1.62
The comet assay: what can it really tell us? Mutat Res (1997) 1.62
Alcohol abuse: potential role in electrolyte disturbances and kidney diseases. Clin Nephrol (1998) 1.54
Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect (1996) 1.43
[Intensive vitamin D supplementation in the treatment of osteoporosis]. Vnitr Lek (2004) 1.41
Evaluation of alternative calculation methods for determining LDL cholesterol. Vnitr Lek (2008) 1.38
Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes. Nephron (1990) 1.38
Cancer in end-stage renal disease: potential factors involved -editorial-. Am J Nephrol (1998) 1.28
Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem (1997) 1.21
Ototoxic side-effects of high doses of frusemide in patients with uraemia. Postgrad Med J (1971) 1.12
Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat Res (2001) 1.11
Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function. J Lab Clin Med (1992) 1.08
Single cell gel electrophoresis: detection of DNA damage at different levels of sensitivity. Electrophoresis (1999) 1.08
Inter-individual differences in repair of DNA base oxidation, measured in vitro with the comet assay. Mutagenesis (2001) 1.04
[Possibilities and limitations of high dosage diuretic therapy in hydropic renal insufficiency]. Dtsch Med Wochenschr (1969) 1.03
Detection of alkylation damage in human lymphocyte DNA with the comet assay. Acta Biochim Pol (2001) 0.99
Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses: a compartmental modeling. Methods Find Exp Clin Pharmacol (1995) 0.98
DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med (1998) 0.98
Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2). Clin Nutr (2000) 0.97
[Guanfacinum (BS 100-14) in long-term therapy of severe hypertension]. Verh Dtsch Ges Inn Med (1978) 0.96
Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med (2001) 0.96
Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol Dial Transplant (1995) 0.95
Role of lysosomal cathepsin activities in cell hypertrophy induced by NH4Cl in cultured renal proximal tubule cells. J Am Soc Nephrol (1996) 0.92
[Acute, reversible hearing damages due to rapid high-dosage furosemide infusions in terminal renal insufficiency]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1970) 0.92
Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function. Kidney Int (2007) 0.91
Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH. Kidney Int (1998) 0.91
Mutagenesis by asbestos in the lung of lambda-lacI transgenic rats. Mutat Res (2004) 0.91
Beta-adrenergic blockade in stress protection. Limited effect of metoprolol in psychological stress reaction. Eur J Clin Pharmacol (1978) 0.89
Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2). Clin Nutr (2000) 0.88
N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis (2001) 0.88
Biomonitoring of genotoxic risk in workers in a rubber factory: comparison of the Comet assay with cytogenetic methods and immunology. Mutat Res (1999) 0.87
Mono- and divalent electrolyte patterns, pCO 2 and pH in relation to flow rate in normal human parotid saliva. Eur J Clin Invest (1972) 0.87
[Beta2-microblogulin in serums: a measure of glomerular filtration]. Dtsch Med Wochenschr (1974) 0.87
Advanced glycation end products and nutrition. Physiol Res (2002) 0.87
Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure. Kidney Int Suppl (2001) 0.87
Calcium antagonists in the treatment of hypertension. Contrib Nephrol (1982) 0.86
Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1. FEBS Lett (1997) 0.86
Advanced glycation end products in end-stage renal disease and their removal. Nephron (2001) 0.86
Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. Artif Organs (1995) 0.86
Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1. Cell Mol Biol (Noisy-le-grand) (1998) 0.85
Studies on natriuretic properties of methylguanidine. Res Exp Med (Berl) (1972) 0.85
Mechanisms and clinical significance of cell volume regulation. Nephrol Dial Transplant (1998) 0.85
Blood rheology and hypertension in hemodialysis patients treated with erythropoietin. Am J Nephrol (1988) 0.85
Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3. Physiol Res (2010) 0.84
Influence of food restriction on dopamine receptor densities, catecholamine concentrations and dopamine turnover in chicken brain. Neuroscience (1999) 0.84
Biomonitoring of occupational exposure to styrene in a plastics lamination plant. Mutat Res (1999) 0.84
Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation. Transplant Proc (1996) 0.83
Effects of diet and age on oxidative damage products in healthy subjects. Physiol Res (2007) 0.83
Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. Eur J Nutr (2001) 0.83
Traditional and alternative nutrition--levels of homocysteine and lipid parameters in adults. Scand J Clin Lab Invest (2000) 0.83
Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. Kidney Int Suppl (1983) 0.82
The prevalence of insulin resistance in kidney disease patients before the development of renal failure. Nephron (1995) 0.82
Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies. Nephrol Dial Transplant (1990) 0.82
Uremic pneumonitis. Evidence for participation of proteolytic enzymes. Contrib Nephrol (1984) 0.82
Effect of chronic therapy with proteolytic enzymes on hypertension-induced renal injury in the rat model of Goldblatt hypertension. Am J Nephrol (1998) 0.82
Inhibitor(s) of protein synthesis in uremic serum and urine: partial purification and relationship to amino acid transport. Biochem Med (1982) 0.82
Mutagenesis by man-made mineral fibres in the lung of rats. Mutat Res (2006) 0.82
Biochemical assessment and clinical evaluation of a bilirubin adsorbent column (BR-350) in critically ill patients with intractable jaundice. Int J Artif Organs (1992) 0.82
Acute effect of hydrochlorothiazide on renal calcium and magnesium handling in postmenopausal women. Physiol Res (1999) 0.82
Pilot study for comparison of reticulocyte-micronulei with lymphocyte-micronuclei in human biomonitoring. Toxicol Lett (2005) 0.82
Role of proteases in hypercatabolic patients with renal failure. Kidney Int Suppl (1983) 0.82
Chronic ethanol ingestion enhances catabolism and muscle protease activity in acutely uremic rats. Nephron (1988) 0.82
Circulatory changes during mental stress in tetraplegic and paraplegic man. Klin Wochenschr (1982) 0.82
Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists. Horm Metab Res (2010) 0.82
Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension. J Cardiovasc Pharmacol (1994) 0.82
Hippurate participates in the correction of metabolic acidosis. Kidney Int Suppl (2001) 0.82
Effect of cellular hydration on protein metabolism. Miner Electrolyte Metab (1997) 0.82
Beneficial effect of proteases on allograft arteriosclerosis in a rat aortic model. Nephrol Dial Transplant (1996) 0.82
Role of alcohol in clinical nephrology. Klin Wochenschr (1985) 0.82
Autonomic neuropathy in chronic renal insufficiency. Comparative analysis of diabetic and nondiabetic patients. Nephron (1985) 0.82
Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis (2001) 0.81
Neutrophil activation in acute renal failure and sepsis. Arch Surg (1990) 0.81
Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration: potential role of lysosomal proteinases. Am J Nephrol (1995) 0.81
[Acute kidney failure caused by Hantaviruses]. Ther Umsch (1994) 0.81
Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am J Kidney Dis (1999) 0.81
Products of DNA, protein and lipid oxidative damage in relation to vitamin C plasma concentration. Physiol Res (2006) 0.81
Homocysteine exerts genotoxic and antioxidative effects in vitro. Toxicol In Vitro (2007) 0.81
Carbohydrate metabolism by rat liver slices incubated in serum obtained from uraemic patients. Clin Sci (1969) 0.81
The aging rat kidney displays low glomerular and tubular proteinase activities. Am J Kidney Dis (1994) 0.81
[Increased cAMP concentration in parotid secretion in arterial hypertension: relationship to plasma-renin activity (author's transl)]. Dtsch Med Wochenschr (1975) 0.81
Hippurate participation in the inhibition of glucose utilization in renal failure. Czech Med (1987) 0.81
Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. Nephron (1986) 0.81
Abnormalities of carbohydrate metabolism in spontaneously hypertensive rats. Klin Wochenschr (1988) 0.81
Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. Clin Nephrol (2000) 0.81
Glandular adenylate cyclase system in genetic hypertension: age-dependent response to catecholamines. Eur J Pharmacol (1988) 0.81
Improvement of dialyzer compatibility by reduction of membrane surface area. Clin Nephrol (1986) 0.81
Blood pressure, 5-OH indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserin. J Cardiovasc Pharmacol (1985) 0.80
Participation of P-dependent and P-independent glutaminases in rat kidney ammoniagenesis and their modulation by metabolic acidosis, hippurate and insulin. Physiol Res (1998) 0.80
Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis. Kidney Blood Press Res (1999) 0.80
Serum hippurate and its excretion in conservatively treated and dialysed patients with chronic renal failure. Physiol Res (1991) 0.80